Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ISRCTN52580708) titled 'The effectiveness of a supplement containing standardized Cosmos caudatus extract on memory, mood and cognitive-related biomarkers in the ageing population with mild cognitive impairment' on Sept. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Prevention
Primary Sponsor: Aurora Health Sdn. Bhd.
Condition:
Mild cognitive impairment (MCI)
Mental and Behavioural Disorders
Intervention:
This study will be a randomized double-blind placebo-controlled trial. Eligible participants will be equally d...